Carcinotech and CELLINK plan to revolutionize the drug discovery market by leveraging CELLINK’s bioprinting solutions and Carcinotech’s expertise in producing 3D bioprinted living tumors to provide protocols for users to develop cutting-edge cancer models. (October 4th 2023, Gothenburg, Sweden) Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for […] The post Carcinotech and CELLINK Enter a Partnership to Develop and Comm...
